Transition Bio

• Gregory Miller

  CEO

• Shilpi Arora

  President and Chief Scientific Officer

• Sarah Teichmann

  Scientific Co-Founder

• Peter St George-Hyslop

  Scientific Co-Founder

• David A. Weitz

  Scientific Co-Founder

• Stephanie Torruella

  Secretary

• Preet Makkar

  Executive officer

• George Martin

  Executive officer

Sources: transitionbio.com, sec.gov

• Samuel Cohen

• G. Kelly Martin

• Sarah Teichmann

• Peter St George-Hyslop

• Tuomas Knowles

• David A. Weitz

Sources: transitionbio.com

• Kathy Yi

  Board director

• Robert Weeks

  Board director

• Alfred W. Sandrock, Jr.

  Board director

• Samuel Cohen

  Board director

• Gregory Bokar

  Board director

• Diana Bernstein

  Board director

• G. Kelly Martin

  Executive Chairman, Co-Founder

• Tuomas Knowles

  Board director

• Al Sandrock

  Board director

• Paxton Major

  Board director

• George Martin

  Board director

Sources: transitionbio.com, sec.gov

• Venture

  US$13.3m, 30 Oct 2024

• Series A

  US$50m, 2 Jun 2022

Sources: news.google.com

• Northpond Ventures

  Venture, 30 Oct 2024

Sources: news.google.com

• Proteostasis

Sources: transitionbio.com